Clinical trial
Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
NCT00231101 · Arthur P. Noyes Research Foundation, Other · Unknown status
Key facts
| NCT number | NCT00231101 |
|---|---|
| Title | Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia |
| Official title | Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia |
| Lead sponsor | Arthur P. Noyes Research Foundation, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Smoking Behavior in Schizophrenia |
| Intervention type | Drug |
| Interventions | Quetiapine |
| Enrollment | 40 |
| Start date | Jan 1, 2004 |
| Completion | Jun 1, 2006 |
| First posted | Oct 4, 2005 |
| Last update posted | Oct 17, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: